Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

355
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
355
Hazard Ratio01:12

Hazard Ratio

308
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
308
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

974
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
974
Introduction to R01:11

Introduction to R

3.0K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
3.0K
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

687
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
687

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beware the Little Foxes that Spoil the Vines: Small Inconsistencies in Clinical Data Can Distort Machine Learning Findings.

Fortune journal of health sciences·2026
Same author

The Common Fund Data Ecosystem (CFDE).

bioRxiv : the preprint server for biology·2026
Same author

Coding Fairness: Detecting Demographic-Related Coding Discrepancies in ICD Code Assignments.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

KG2ML: integrating knowledge graphs and positive unlabeled learning for identifying disease-associated genes.

Frontiers in bioinformatics·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Badapple 2.0: An Empirical Predictor of Compound Promiscuity, Updated, Modernized, and Enhanced for Explainability.

Journal of chemical information and modeling·2025
Same journal

ebnm: An R Package for Solving the Empirical Bayes Normal Means Problem Using a Variety of Prior Families.

Journal of statistical software·2026
Same journal

Optimum Allocation for Adaptive Multi-Wave Sampling in R: The R Package optimall.

Journal of statistical software·2025
Same journal

BoXHED2.0: Scalable Boosting of Dynamic Survival Analysis.

Journal of statistical software·2025
Same journal

Probabilistic Estimation and Projection of the Annual Total Fertility Rate Accounting for Past Uncertainty: A Major Update of the bayesTFR R Package.

Journal of statistical software·2024
Same journal

PResiduals: An R Package for Residual Analysis Using Probability-Scale Residuals.

Journal of statistical software·2024
Same journal

Regression Modeling for Recurrent Events Possibly with an Informative Terminal Event Using R Package reReg.

Journal of statistical software·2024
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

LocalControl: An R Package for Comparative Safety and Effectiveness Research.

Nicolas R Lauve1, Stuart J Nelson1, S Stanley Young2

  • 1University of New Mexico.

Journal of Statistical Software
|August 5, 2021
PubMed
Summary
This summary is machine-generated.

The LocalControl R package offers novel methods to reduce bias in observational studies. It enables high-quality evidence generation for treatment comparisons, improving personalized predictions and subgroup analyses.

Keywords:
Kaplan-MeierRbiascompeting riskssurvival

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

446
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

512

Related Experiment Videos

Last Updated: Oct 25, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

446
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

512

Area of Science:

  • Biostatistics
  • Health Informatics
  • Epidemiology

Background:

  • Observational studies are crucial for comparative effectiveness research but susceptible to bias and confounding.
  • Existing methods may not adequately address complex scenarios like competing risks or censoring.

Purpose of the Study:

  • To introduce the LocalControl R package, providing novel bias correction methods for observational studies.
  • To enable robust comparisons of treatments or exposures and enhance personalized predictions.

Main Methods:

  • Implementation of a family of non-parametric bias correction methods within the LocalControl R package.
  • Application to comparative effectiveness research, including survival analysis with competing risks and censoring.

Main Results:

  • The LocalControl package provides tools for bias correction in observational data.
  • Enables bias-corrected personalized predictions of treatment outcome differences.
  • Facilitates analysis of treatment effect heterogeneity across patient subgroups.

Conclusions:

  • LocalControl is an open-source tool for generating high-quality evidence from observational data.
  • It addresses critical challenges in comparative safety and effectiveness research.
  • The package supports advanced analyses, including personalized treatment effect estimation.